
Integra LifeSciences Holdings Corporation IART
$ 12.65
-0.08%
Quarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Total Non Current Liabilities 2011-2025 | IART
Annual Total Non Current Liabilities Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.56 B | 1.47 B | 1.9 B | 845 M | 884 M | 748 M | 407 M | 539 M | 550 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.9 B | 407 M | 989 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
19.1 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.47 | -3.61 % | $ 120 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 96.06 | -0.04 % | $ 141 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 9.35 | -1.99 % | $ 671 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 303.76 | 0.52 % | $ 8.57 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 47.89 | -0.48 % | $ 7.14 K | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 124.72 | -0.1 % | $ 217 B | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.3 | 11.09 % | $ 123 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
InMode Ltd.
INMD
|
12 M | $ 14.62 | 1.04 % | $ 1.16 B | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.21 | 6.14 % | $ 19.5 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
LivaNova PLC
LIVN
|
516 M | $ 62.92 | -0.25 % | $ 3.41 B | ||
|
Align Technology
ALGN
|
184 M | $ 158.62 | 0.49 % | $ 11.9 B | ||
|
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.83 | -3.49 % | $ 85.3 M | ||
|
LENSAR
LNSR
|
3.44 M | $ 12.03 | 0.17 % | $ 139 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 97.53 | 0.48 % | $ 1.24 B | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 14.04 | -3.13 % | $ 379 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 14.51 | -0.13 % | $ 95.1 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 32.87 | 0.7 % | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 40.89 | 2.12 % | $ 1.26 B | ||
|
OrthoPediatrics Corp.
KIDS
|
84.7 M | $ 17.36 | -0.29 % | $ 401 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 88.38 | -0.15 % | $ 12 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Aethlon Medical
AEMD
|
42.5 K | $ 2.58 | 3.61 % | $ 4.03 M | ||
|
Myomo
MYO
|
275 K | $ 1.02 | - | $ 7.19 M |